New-DES vs BMS in SVG -1 Year Outcomes

Medical University of Silesia792 enrolled

Overview

Data regarding the efficacy of the percutaneous coronary intervention (PCI) with new-designed drug-eluting stent (new-DES) vs. bare metal stent (BMS) of saphenous vein grafts (SVG) stenosis is scarce. The primary objective was to compare one-year clinical outcomes of PCI in stenosis of SVG using new-DES vs. BMS in a real-world population. We carried out a multi-center registry comparing new-DES with BMS in all consecutive patients undergoing PCI of SVG. The primary composite endpoint was major adverse cardiac and cerebrovascular events (MACCE) at 1 year.

Study Type

OBSERVATIONAL

Enrollment

792

Conditions

Coronary Artery Disease

Interventions

new-DESDEVICE

with ot without embolic protection device

BMSDEVICE

with ot without embolic protection device

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: * patients after CABG with significant SVG stenosis referred for PCI Exclusion Criteria: * patients who had both types of stents implanted in the same procedure * patients with the old-DES * patients who had PCI of other vascular territories during the same procedure

Locations (3)

First Department of Cardiology, Medical University of Gdansk, Gdansk, Poland

Gdansk, Poland

Department of Cardiology and Structural Heart Diseases, Medical University of Silesia, Katowice, Poland

Katowice, Poland

Second Department of Cardiology, Jagiellonian University Medical College, Krakow, Poland

Krakow, Poland

Outcomes

Primary Outcomes

major adverse cardiac and cerebrovascular event

Time frame: 1 year

Secondary Outcomes

death

Time frame: 1 year

myocardial infarction

Time frame: 1 year

target vessel revascularization

Time frame: 1 year

target lesion revascularization

Time frame: 1 year

stroke

Time frame: 1 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.